Editorial comment on "Disregarding clinical trial-based patient-reported outcomes is unwarranted: Five advances to substantiate the scientific stringency of quality-of-life measurement"
Acta Oncol
.
2010;49(2):163-5.
doi: 10.3109/02841860903473297.
Authors
Birgitta Johansson
1
,
Sussanne Börjeson
,
Karin Nordin
,
Ann Langius-Eklöf
Affiliation
1
Department of Oncology, Uppsala University Hospital, Uppsala, Sweden. birgitta.johansson@onkologi.uu.se
PMID:
20100153
DOI:
10.3109/02841860903473297
No abstract available
Publication types
Comment
MeSH terms
Clinical Trials as Topic*
Humans
Neoplasms / therapy*
Quality of Life*
Treatment Outcome